The majority of the ADPKD patients has mutations in PKD1 or PKD2, which encode polycystin‐1 (PC1) and polycystin‐2 (PC2), respectively (Cornec‐Le Gall et al., 2018). Here, PKD2 is linked to autosomal dominant polycystic kidney disease.